vs
Side-by-side financial comparison of C.H. Robinson (CHRW) and Stryker Corporation (SYK). Click either name above to swap in a different company.
Stryker Corporation is the larger business by last-quarter revenue ($7.2B vs $3.9B, roughly 1.8× C.H. Robinson). Stryker Corporation runs the higher net margin — 11.8% vs 3.5%, a 8.4% gap on every dollar of revenue. On growth, Stryker Corporation posted the faster year-over-year revenue change (11.4% vs -6.5%). Stryker Corporation produced more free cash flow last quarter ($1.9B vs $302.4M). Over the past eight quarters, Stryker Corporation's revenue compounded faster (16.9% CAGR vs -5.8%).
C.H. Robinson Worldwide, Inc. is an American transportation company that includes third-party logistics (3PL). The company offers freight transportation, transportation management, brokerage and warehousing. It offers truckload, less than truckload, air freight, intermodal, and ocean transportation.
The Stryker is a family of eight-wheeled armored fighting vehicles derived from the Canadian LAV III, which in turn derived from the Swiss Mowag Piranha. Stryker vehicles are produced by General Dynamics Land Systems-Canada (GDLS-C) for the United States Army in a plant in London, Ontario. It has four-wheel drive (8×4) and can be switched to all-wheel drive (8×8).
CHRW vs SYK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.9B | $7.2B |
| Net Profit | $136.3M | $849.0M |
| Gross Margin | — | 64.5% |
| Operating Margin | 4.6% | 25.2% |
| Net Margin | 3.5% | 11.8% |
| Revenue YoY | -6.5% | 11.4% |
| Net Profit YoY | -8.7% | 55.5% |
| EPS (diluted) | $1.12 | $2.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9B | $7.2B | ||
| Q3 25 | $4.1B | $6.1B | ||
| Q2 25 | $4.1B | $6.0B | ||
| Q1 25 | $4.0B | $5.9B | ||
| Q4 24 | $4.2B | $6.4B | ||
| Q3 24 | $4.6B | $5.5B | ||
| Q2 24 | $4.5B | $5.4B | ||
| Q1 24 | $4.4B | $5.2B |
| Q4 25 | $136.3M | $849.0M | ||
| Q3 25 | $163.0M | $859.0M | ||
| Q2 25 | $152.5M | $884.0M | ||
| Q1 25 | $135.3M | $654.0M | ||
| Q4 24 | $149.3M | $546.0M | ||
| Q3 24 | $97.2M | $834.0M | ||
| Q2 24 | $126.3M | $825.0M | ||
| Q1 24 | $92.9M | $788.0M |
| Q4 25 | — | 64.5% | ||
| Q3 25 | — | 63.6% | ||
| Q2 25 | — | 63.8% | ||
| Q1 25 | — | 63.8% | ||
| Q4 24 | — | 64.9% | ||
| Q3 24 | — | 64.0% | ||
| Q2 24 | — | 63.0% | ||
| Q1 24 | — | 63.6% |
| Q4 25 | 4.6% | 25.2% | ||
| Q3 25 | 5.3% | 18.7% | ||
| Q2 25 | 5.2% | 18.5% | ||
| Q1 25 | 4.4% | 14.3% | ||
| Q4 24 | 4.4% | 9.0% | ||
| Q3 24 | 3.9% | 19.7% | ||
| Q2 24 | 4.0% | 19.4% | ||
| Q1 24 | 2.9% | 18.5% |
| Q4 25 | 3.5% | 11.8% | ||
| Q3 25 | 3.9% | 14.2% | ||
| Q2 25 | 3.7% | 14.7% | ||
| Q1 25 | 3.3% | 11.1% | ||
| Q4 24 | 3.6% | 8.5% | ||
| Q3 24 | 2.1% | 15.2% | ||
| Q2 24 | 2.8% | 15.2% | ||
| Q1 24 | 2.1% | 15.0% |
| Q4 25 | $1.12 | $2.20 | ||
| Q3 25 | $1.34 | $2.22 | ||
| Q2 25 | $1.26 | $2.29 | ||
| Q1 25 | $1.11 | $1.69 | ||
| Q4 24 | $1.23 | $1.41 | ||
| Q3 24 | $0.80 | $2.16 | ||
| Q2 24 | $1.05 | $2.14 | ||
| Q1 24 | $0.78 | $2.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $160.9M | $4.0B |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $1.8B | $22.4B |
| Total Assets | $5.1B | $47.8B |
| Debt / EquityLower = less leverage | 0.59× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $160.9M | $4.0B | ||
| Q3 25 | $136.8M | $3.3B | ||
| Q2 25 | $156.0M | $2.4B | ||
| Q1 25 | $129.9M | $2.3B | ||
| Q4 24 | $145.8M | $3.7B | ||
| Q3 24 | $131.7M | $3.9B | ||
| Q2 24 | $113.2M | $1.9B | ||
| Q1 24 | $121.8M | $2.3B |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | $1.7B | — |
| Q4 25 | $1.8B | $22.4B | ||
| Q3 25 | $1.9B | $21.8B | ||
| Q2 25 | $1.8B | $21.2B | ||
| Q1 25 | $1.7B | $20.9B | ||
| Q4 24 | $1.7B | $20.6B | ||
| Q3 24 | $1.6B | $20.1B | ||
| Q2 24 | $1.5B | $19.8B | ||
| Q1 24 | $1.4B | $19.2B |
| Q4 25 | $5.1B | $47.8B | ||
| Q3 25 | $5.2B | $47.1B | ||
| Q2 25 | $5.3B | $46.3B | ||
| Q1 25 | $5.2B | $46.0B | ||
| Q4 24 | $5.3B | $43.0B | ||
| Q3 24 | $5.6B | $43.8B | ||
| Q2 24 | $5.5B | $39.1B | ||
| Q1 24 | $5.5B | $39.4B |
| Q4 25 | 0.59× | — | ||
| Q3 25 | 0.64× | — | ||
| Q2 25 | 0.76× | — | ||
| Q1 25 | 0.80× | — | ||
| Q4 24 | 0.80× | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | 1.07× | — | ||
| Q1 24 | 1.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $305.4M | $2.1B |
| Free Cash FlowOCF − Capex | $302.4M | $1.9B |
| FCF MarginFCF / Revenue | 7.7% | 26.1% |
| Capex IntensityCapex / Revenue | 0.1% | 3.7% |
| Cash ConversionOCF / Net Profit | 2.24× | 2.52× |
| TTM Free Cash FlowTrailing 4 quarters | $894.9M | $4.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $305.4M | $2.1B | ||
| Q3 25 | $275.4M | $1.5B | ||
| Q2 25 | $227.1M | $1.1B | ||
| Q1 25 | $106.5M | $250.0M | ||
| Q4 24 | $267.9M | $1.9B | ||
| Q3 24 | $108.1M | $1.5B | ||
| Q2 24 | $166.4M | $633.0M | ||
| Q1 24 | $-33.3M | $204.0M |
| Q4 25 | $302.4M | $1.9B | ||
| Q3 25 | $269.5M | $1.4B | ||
| Q2 25 | $219.8M | $928.0M | ||
| Q1 25 | $103.2M | $127.0M | ||
| Q4 24 | $265.3M | $1.7B | ||
| Q3 24 | $103.3M | $1.3B | ||
| Q2 24 | $159.8M | $481.0M | ||
| Q1 24 | $-41.9M | $37.0M |
| Q4 25 | 7.7% | 26.1% | ||
| Q3 25 | 6.5% | 22.3% | ||
| Q2 25 | 5.3% | 15.4% | ||
| Q1 25 | 2.5% | 2.2% | ||
| Q4 24 | 6.3% | 25.9% | ||
| Q3 24 | 2.2% | 23.7% | ||
| Q2 24 | 3.6% | 8.9% | ||
| Q1 24 | -1.0% | 0.7% |
| Q4 25 | 0.1% | 3.7% | ||
| Q3 25 | 0.1% | 3.1% | ||
| Q2 25 | 0.2% | 3.0% | ||
| Q1 25 | 0.1% | 2.1% | ||
| Q4 24 | 0.1% | 4.1% | ||
| Q3 24 | 0.1% | 3.1% | ||
| Q2 24 | 0.1% | 2.8% | ||
| Q1 24 | 0.2% | 3.2% |
| Q4 25 | 2.24× | 2.52× | ||
| Q3 25 | 1.69× | 1.79× | ||
| Q2 25 | 1.49× | 1.26× | ||
| Q1 25 | 0.79× | 0.38× | ||
| Q4 24 | 1.79× | 3.54× | ||
| Q3 24 | 1.11× | 1.77× | ||
| Q2 24 | 1.32× | 0.77× | ||
| Q1 24 | -0.36× | 0.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CHRW
| North American Service Transportation NAST | $2.8B | 72% |
| Global Forwarding | $731.0M | 19% |
| Sourcing | $340.9M | 9% |
SYK
| Medical | $1.3B | 18% |
| Endoscopy | $1.1B | 16% |
| Traumaand Extremities | $1.1B | 15% |
| Instruments | $925.0M | 13% |
| Knees | $749.0M | 10% |
| Neuro Cranial | $669.0M | 9% |
| Neurovascular | $539.0M | 8% |
| Hips | $499.0M | 7% |
| Other Orthopaedics | $267.0M | 4% |
| Spine | $8.0M | 0% |
